MedTrace Logo

Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

NCT01819935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5271

Last updated 2014-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatment and among subpopulations.

Conditions

Interventions

DRUG

linezolid (Zyvox)

As prescribed-this is retrospective cohort of existing clinical data.

DRUG

vancomycin

As prescribed-this is retrospective cohort of existing clinical data.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01819935 on ClinicalTrials.gov